Resurge Therapeutics, a clinical-stage urology company, today announced positive clinical results from two studies evaluating its proprietary IntraProstatic Drug Elution (IPDE) therapy. The IPDE ...

New Clinical and Translational Data Presented at Major Medical Meetings Further Confirms the Disease-Modifying Potential of Nebokitug in Primary ...

A high-end course that the president’s top fundraiser has proposed for East Potomac Park could sharply limit access for ...

Management highlighted that most remaining 2026 revenue is already contracted or highly forecastable, with a smaller ...

Multinational Real-world Data Reinforce Favorable Clinical Profile and Long-Term Safety SOUTH SAN FRANCISCO, Calif., May 11, 2026 (GLOBE ...

The US Sustainable Investment Forum (US SIF) is proud to welcome George H. Walker, Chairman and CEO of Neuberger, as a keynote speaker at US SIF FORUM 2026. US SIF's annual conference, the premier ...

Investigational New Drug application for KHN921 received 'study may proceed” from the US FDA. KHN921 is a potential 'first-in-class' cardiovascular AAV gene therapy being developed for the treatment o ...

TAGMO Clinical Readouts -- Initial results for head and neck, and upper GI adenocarcinoma cohorts are expected midyear, with ...

Shareholder/Analyst Call May 13, 2026 11:00 AM EDTCompany ParticipantsBryan Tiede - Chief Risk OfficerJoseph Turner ...

Operator: Greetings, and welcome to the Griffon Corporation Fiscal Second Quarter 2026 Earnings Call. [Operator Instructions] ...

What the heck are space balls? If you’re updating your kitchen soon, you best find out! Learn about this and other odd terms ...

Growing up, Motor Trend was basically Chris' bible. With an ever growing TikTok fan base, Chris decided it was time to take the more serious journalistic approach to talking about his favorite subject ...